2006
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced preliminary, unaudited first quarter revenues of approximately $894 million, reflecting a decline of approximately 6 percent...
Company Expects European Launch of XIENCE V in Third Quarter 2006 Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that a small percentage (approximately 1 percent) of the...
Panel Chaired by Dr. Myerburg, an Internationally Recognized Leader in Electrophysiology; In-Depth Analyses and Eight Major Recommendations Provided to the Corporation Indianapolis, Ind. - Guidant...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced that the first patient has been enrolled in a new post-approval study of carotid artery stenting in...
Drug Eluting and Carotid Stents, Emerging Therapies Drive Expansion Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced that it will begin construction on expanded facilities in...
Large-Scale Trial Evaluating Safety and Efficacy of Next-Generation XIENCE(tm) V Coronary Stent System Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced...
Results from 2,500 Patients Suggest Therapy Can Be Performed Safely by Broad Group of Physicians Indianapolis, Ind. and Atlanta - Guidant Corporation (NYSE: GDT) today announced updated results of...
Guidant Initiates Voluntary Worldwide Physician Communication Regarding Implantable Cardiac Defibrillators Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today it is voluntarily...
R. Frederick McCoy, Jr., Elects Early Retirement from Guidant Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Fred McCoy, president, Guidant Cardiac Rhythm Management,...
RX HERCULINK ELITE Biliary Stent System Provides Superb Deliverability with Increased Radial Strength, Visibility and Stent Flexibility Indianapolis, Ind. and Santa Clara, Calif. - Guidant...
Innovative Technology Could Represent New Frontier in the Treatment of Heart Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced enrollment of the...
Company Reports One Inspection Observation and Reiterates Anticipated Readiness for Mid-Year Re-Inspection Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced today that the U.S. Food...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a first quarter dividend of $0.10 per share on outstanding common stock. The...
Company Achieves CE Mark Approval Ahead of Schedule; XIENCE V Launch Slated for Second Quarter Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE: GDT) today announced that the company...
Earnings from continuing operations of $85 million or $0.25 per share compared to guidance of $0.17-$0.23 per share Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the...
Cancels Special Meeting of Shareholders; Enters Into Agreement with Boston Scientific Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it has terminated its merger...
Boston Scientific and Guidant Announce Signing of Merger Agreement Valued at $27 Billion
Natick, MA and Indianapolis, IN - Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that the Board of Directors of Guidant has unanimously approved and...
Company Has Successfully Completed Conformity Assessment and Facility Audit by Notified Body; CE Mark Certificate Expected in 7-10 Days Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE:...
ndianapolis, Ind. - Guidant Corporation (NYSE: GDT) is voluntarily advising and updating physicians about important safety information regarding certain older model pacemakers. This communication...
Guidant''s Board to Evaluate Offer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) acknowledges receipt today, , of an amended offer from Boston Scientific Corporation to acquire Guidant for...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that its Board of Directors has determined that Boston Scientific's revised offer to acquire Guidant is superior to the terms...
Guidant Shareholder Vote Remains Set for January 31 Indianapolis and New Brunswick, N.J. - Guidant Corporation (NYSE: GDT) and Johnson & Johnson (NYSE:JNJ) today announced that they have reached a...
Guidant''s Board to Evaluate Offer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) acknowledges receipt today, , of an amended offer from Boston Scientific Corporation to acquire Guidant for...
Guidant Shareholder Vote Remains Set for January 31 Indianapolis and New Brunswick, N.J. - Guidant Corporation (NYSE: GDT) and Johnson & Johnson (NYSE:JNJ) today announced that they have reached a...
Guidant Receives Anticipated FDA Follow-up Letter; No New Observations Cited Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that management believes preliminary, unaudited...